Cannabidiol (CBD), a non-psychoactive compound found in the cannabis plant, has emerged as a potential therapeutic agent for Alzheimer’s Disease. While research is still in the early stages, several studies have shown that CBD may help prevent and alleviate some of the disease’s symptoms.
Alzheimer’s disease (AD) affects 6.5 million people in the U.S. Of the 55 million people worldwide with dementia, nearly 70% are estimated to have Alzheimer’s. The Alzheimer’s Association says that by 2050, the number of people over 65 with Alzheimer’s could grow to 12.7 million.
As there is no cure for Alzheimer’s, available treatments can only focus on symptom relief. However, CBD showed promise in recent research undertaken at China Pharmaceutical University, where experts looked at the neuroprotective and anti-inflammatory mechanisms of the cannabinoid in a study called “Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration,” published in the journal Cells.
“Our findings suggest CBD’s efficacy in moderating microglial and astrocytic activation, offering anti-inflammatory benefits that protect synaptic function and alleviate AD-associated cognitive deficits,” authors noted. “Our data support CBD’s potential therapeutic role in countering AD-related neuroinflammation.”
The Role Of CBD In Alzheimer’s Disease
The recent study investigated the potential of CBD to improve cognitive function…
